Literature DB >> 19262989

Killer B lymphocytes: the evidence and the potential.

Steven K Lundy1.   

Abstract

Immune regulation plays a critical role in controlling potentially dangerous inflammation and maintaining health. The Fas ligand/Fas receptor axis has been studied extensively as a mechanism of killing T cells and other cells during infections, autoimmunity, and cancer. FasL expression has been primarily attributed to activated T cells and NK cells. Evidence has emerged that B lymphocytes can express FasL and other death-inducing ligands, and can mediate cell death under many circumstances. Among B cell subsets, the expression of both Fas ligand and IL-10 is highest on the CD5(+) B cell population, suggesting that CD5(+) B cells may have a specialized regulatory function. The relevance of killer B cells to normal immune regulation, disease pathogenesis, and inflammation is discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19262989      PMCID: PMC2892642          DOI: 10.1007/s00011-009-0014-x

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  111 in total

1.  Identification of a B-1 B cell-specified progenitor.

Authors:  Encarnacion Montecino-Rodriguez; Hyosuk Leathers; Kenneth Dorshkind
Journal:  Nat Immunol       Date:  2006-01-22       Impact factor: 25.606

Review 2.  A case for regulatory B cells.

Authors:  Atsushi Mizoguchi; Atul K Bhan
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

3.  B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice.

Authors:  Danielle Bonardelle; Karim Benihoud; Nicole Kiger; Pierre Bobé
Journal:  J Leukoc Biol       Date:  2005-10-04       Impact factor: 4.962

4.  The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice.

Authors:  Yasuhito Hamaguchi; Junji Uchida; Derek W Cain; Guglielmo M Venturi; Jonathan C Poe; Karen M Haas; Thomas F Tedder
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

5.  Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets.

Authors:  Bo Wei; Peter Velazquez; Olga Turovskaya; Karsten Spricher; Richard Aranda; Mitchell Kronenberg; Lutz Birnbaumer; Jonathan Braun
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

Review 6.  Regulatory roles for cytokine-producing B cells in infection and autoimmune disease.

Authors:  Frances E Lund; Beth A Garvy; Troy D Randall; David P Harris
Journal:  Curr Dir Autoimmun       Date:  2005

7.  Helminth infection protects mice from anaphylaxis via IL-10-producing B cells.

Authors:  Niamh E Mangan; Rosemary E Fallon; Philip Smith; Nico van Rooijen; Andrew N McKenzie; Padraic G Fallon
Journal:  J Immunol       Date:  2004-11-15       Impact factor: 5.422

8.  Deficiency of regulatory B cells increases allergic airway inflammation.

Authors:  S K Lundy; A A Berlin; T F Martens; N W Lukacs
Journal:  Inflamm Res       Date:  2005-12       Impact factor: 4.575

9.  Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis.

Authors:  Maria J Leandro; Geraldine Cambridge; Michael R Ehrenstein; Jonathan C W Edwards
Journal:  Arthritis Rheum       Date:  2006-02

Review 10.  The B7 family of immune-regulatory ligands.

Authors:  Mary Collins; Vincent Ling; Beatriz M Carreno
Journal:  Genome Biol       Date:  2005-05-31       Impact factor: 13.583

View more
  38 in total

Review 1.  Regulatory B cells in autoimmunity: developments and controversies.

Authors:  Claudia Mauri; Paul A Blair
Journal:  Nat Rev Rheumatol       Date:  2010-09-21       Impact factor: 20.543

2.  [Regulatory B cells and their role in maintaining peripheral tolerance].

Authors:  T Tretter; H-M Lorenz
Journal:  Z Rheumatol       Date:  2010-11       Impact factor: 1.372

3.  The parity-associated microenvironmental niche in the omental fat band is refractory to ovarian cancer metastasis.

Authors:  Courtney A Cohen; Amanda A Shea; C Lynn Heffron; Eva M Schmelz; Paul C Roberts
Journal:  Cancer Prev Res (Phila)       Date:  2013-09-10

4.  Coxiella burnetii Avirulent Nine Mile Phase II Induces Caspase-1-Dependent Pyroptosis in Murine Peritoneal B1a B Cells.

Authors:  Laura Schoenlaub; Rama Cherla; Yan Zhang; Guoquan Zhang
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

5.  Upregulation of CD19⁺CD24(hi)CD38(hi) regulatory B cells is associated with a reduced risk of acute lung injury in elderly pneumonia patients.

Authors:  Haihan Song; Jianjun Xi; Guang-Gang Li; Shumin Xu; Chunmei Wang; Tingting Cheng; Hongqiang Li; Ying Zhang; Xiandong Liu; Jianwen Bai
Journal:  Intern Emerg Med       Date:  2016-01-12       Impact factor: 3.397

Review 6.  Multiple mechanisms of immune suppression by B lymphocytes.

Authors:  Matthew W Klinker; Steven K Lundy
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

7.  Role of B cells in host defense against primary Coxiella burnetii infection.

Authors:  Laura Schoenlaub; Alexandra Elliott; Danielle Freches; William J Mitchell; Guoquan Zhang
Journal:  Infect Immun       Date:  2015-10-05       Impact factor: 3.441

8.  Innate pro-B-cell progenitors protect against type 1 diabetes by regulating autoimmune effector T cells.

Authors:  Ruddy Montandon; Sarantis Korniotis; Esther Layseca-Espinosa; Christophe Gras; Jérôme Mégret; Sophie Ezine; Michel Dy; Flora Zavala
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

9.  Antigen-specific suppression of humoral immunity by anergic Ars/A1 B cells.

Authors:  Katja Aviszus; Megan K L Macleod; Greg A Kirchenbaum; Thiago O Detanico; Ryan A Heiser; James B St Clair; Wenzhong Guo; Lawrence J Wysocki
Journal:  J Immunol       Date:  2012-09-24       Impact factor: 5.422

10.  Reduced Fas ligand-expressing splenic CD5+ B lymphocytes in severe collagen-induced arthritis.

Authors:  Steven K Lundy; David A Fox
Journal:  Arthritis Res Ther       Date:  2009-08-25       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.